Amarin Corp Plc (AMRN)

[rafunrafun]

Scripts for week ending September 30, 2022

Drug Industry TRx: -0.8% w/w; +7.1% y/y

VASCEPA
TRx 62,703; -1.0% (-640) w/w; -22.8% y/y
NRx 28,824; -0.9% (-252) w/w; -22.6% y/y
Ref 33,879; -1.1% (-388) w/w; -22.9% y/y

Fake Vascepa
TRx 39,177; -4.4% (-1,817) w/w; As % of total V: 38.5%
NRx 19,160; -5.4% (-1,096) w/w; As % of total V: 39.9%
Ref 20,017; -3.5% (-715) w/w; As % of total V: 37.1%

Fake Vascepa by Manufacturer
Hikma - TRx 13,616; (-639) w/w; Generic share 34.8%; Total V share 13.4%
Reddy - TRx 18,154; (-1,334) w/w; Generic share 46.3%; Total V share 17.8%
Apotex - TRx 7,323; (+123) w/w; Generic share 18.7%; Total V share 7.2%
Teva - TRx 84; (+33) w/w; Generic share 0.2%; Total V share 0.1%

VASCEPA + Fake Vascepa
TRx 101,881; -2.4% (-2,457) w/w; +2.1% y/y
NRx 47,985; -2.7% (-1,349) w/w; +0.4% y/y
Ref 53,896; -2.0% (-1,109) w/w; +3.7% y/y

Lovaza (Fake & Brand)
TRx 61,633; -3.5% (-2,211) w/w; -2.4% y/y
NRx 30,155; -2.9% (-895) w/w; -3.0% y/y
Ref 31,478; -4.0% (-1,316) w/w; -1.8% y/y